Literature DB >> 10378694

The role of c-myc in cellular growth control.

E V Schmidt1.   

Abstract

Cell division is coupled to cell growth. Since some c-myc target genes are regulators of cell growth while others function in cell division pathways, c-myc is apparently poised at the interface of these processes. Cell culture systems have shown specific myc-associated growth phenotypes. Increased cell growth precedes DNA synthesis after myc activation in cells expressing myc-estrogen receptor fuson constructs and cells lacking c-myc exhibit a marked loss of protein synthesis. A number of candidate c-myc target genes regulate processes required for cell growth including rRNA transcription and processing, ribosomal protein transcription and translation, and translation initiation. These interactions all have the potential to account for the growth phenotypes in c-myc mutant cells. The ability of translation initiation factors, including eIF4E, to transform cells makes them particularly interesting targets of c-myc. Further evaluation of these target genes will provide important insights into growth control and c-myc's functions in cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378694     DOI: 10.1038/sj.onc.1202751

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  105 in total

Review 1.  How cells use proteolysis to control their growth.

Authors:  W P Tansey
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

2.  Genes encoding ribosomal proteins Rps0A/B of Saccharomyces cerevisiae interact with TOM1 mutants defective in ribosome synthesis.

Authors:  A L Tabb; T Utsugi; C R Wooten-Kee; T Sasaki; S A Edling; W Gump; Y Kikuchi; S R Ellis
Journal:  Genetics       Date:  2001-03       Impact factor: 4.562

3.  S6 phosphorylation-independent pathways regulate translation of 5'-terminal oligopyrimidine tract-containing mRNAs in differentiating hematopoietic cells.

Authors:  Diane Barth-Baus; Carl A Stratton; Lou Parrott; Howard Myerson; Oded Meyuhas; Dennis J Templeton; Gary E Landreth; Jack O Hensold
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

4.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

5.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

6.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 7.  Signaling by target of rapamycin proteins in cell growth control.

Authors:  Ken Inoki; Hongjiao Ouyang; Yong Li; Kun-Liang Guan
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

8.  Intervenolin suppresses gastric cancer cell growth through the induction of TSP-1 secretion from fibroblast-like stromal cells.

Authors:  Junjiro Yoshida; Hikaru Abe; Takumi Watanabe; Manabu Kawada
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

9.  Effect of growth factors on the proliferation and gene expression of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Wendy R Kam; Juan Ding; Mark P Hatton; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

Review 10.  Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.

Authors:  I Gunaseeli; M X Doss; C Antzelevitch; J Hescheler; A Sachinidis
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.